Bill Barrable, Chief Executive Officer
Bill Barrable has been the Chief Executive Officer of the Rick Hansen Institute since January 2010. Bill was the Chief Executive of BC Transplant from 1994 to 2009, during which time it was honoured with the Canada Award for Excellence from the National Quality Institute. In 2001 he became the founding Chair of the Board of Directors of the Michael Smith Foundation for Health Research. In 2008 he co-founded Natalus Life Science Capital (VCC) Inc., an angel fund which invests in BC Biotechnology startup companies.
At BC Transplant he led the creation of the first online digital signature organ donor registry in partnership with a BC company, Recombo Incorporated. He also championed the passage of legislation which enshrined the rights of organ donors into the Human Tissue & Gift Act of BC.
He has been a member of numerous governing boards of various kinds and holds a BA from Queen's University, and a Master of Health Science from the University of Toronto. In 2010, he received the alumni leadership award from the University of Toronto's Society of Graduates in Health Policy, Management and Evaluation. He was previously named one of Canada's Top 40 under 40.
Dr. Phalgun Joshi, PhD, Managing Director, Program Operations & Support
As Managing Director of the Rick Hansen Institute's Program Operations and Support, Phalgun Joshi is responsible for the overall planning, operations, reporting, performance evaluation and regulatory compliance of all translational research and best practice activities at RHI. Phalgun received his PhD in Biochemistry from the University of British Columbia and has published in diverse areas including genomics, gene therapy, drug discovery and parasitology. Prior to joining RHI, Phalgun was Director of Western Operations for PharmEng Technology, an international consulting company providing regulatory compliance and strategic planning services to clients in the health care and life science industries. At PharmEng, Phalgun held primary responsibility for business development, operations and management of regulatory compliance projects in Canada, US, South America, Asia, Europe and Africa.
Dr. Vanessa Noonan, MSc, PhD, PT, Director, Research & Best Practice Implementation
Dr. Vanessa Noonan is a physical therapist and the focus of her research and clinical practice has been in the area of spinal cord injury. Clinically, she has practiced in both the SCI acute and rehabilitation settings. Her research examines processes and outcomes of care following SCI rehabilitation, with the goal of moving research into practice and creating standards of care.
Vanessa obtained her PhD from the UBC School of Population and Public Health in 2009. Her doctoral thesis examined measures of participation in persons with SCI that are based on the International Classification of Functioning, Disability and Health (ICF) model. She later received a post-doctoral fellowship award from the National Institute on Disability and Rehabilitation Research and had the opportunity to work with the NIH-sponsored project PROMIS (Patient-Reported Outcomes Measurement Information System) at the University of Washington.
As Director of Research & Best Practice Implementation, Vanessa is responsible for leading translational research and best practice implementation projects at the Rick Hansen Institute. She has been actively involved with the Rick Hansen Spinal Cord Injury Registry since it started in 2002 and co-led the development of a new community follow-up questionnaire for the Registry. In addition, she is part of the International SCI Data Set Committee, which has overseen the development of 16 data sets that are used internationally. Vanessa is also currently a co-investigator on the Access to Care and Timing project, which is examining the provision of care for persons with SCI in 12 Canadian centres, spanning seven provinces.
Dr. Pamela Berg, PhD, Director, Resource & Policy Development
Pamela Berg has held a number of roles at the Rick Hansen Institute (RHI) and Rick Hansen Foundation (RHF), since 2008. She has focused on Resource Development for RHI since 2010, specializing in Government Relations. Her current role emphasizes the development of partnerships with various organizations, including governments, health research foundations, universities, and private donors.
Pamela started her career in the spinal cord injury field as a Rehabilitation Counsellor at SCI-BC. At RHI and RHF, she has served as Director of Community Partnerships, Senior Manager of Provincial/Territorial Partnerships, and Manager of Government Relations.
In her first career as a chemist, Pamela held research and engineering positions in the petrochemical and laser manufacturing industries. Pamela holds a PhD in Chemical Physics from the University of Waterloo, where she was awarded the Alumni Gold Medal for academic excellence. She also holds a Social Work degree from UBC.
Penny Clarke Richardson, BA, MBA, Director, Strategic Implementation, BSCC Partnerships
Penny Clarke-Richardson is an operational leader with over 25 years' experience in both private and public sectors, including healthcare education, delivery and research, and meeting management. Recent experience focusses on transformational change implementation, IT integration, and safety and quality assurance in the context of system redesign and network development. Expertise in developing goal-oriented, collaborative teams and building consensus in complex, multi-disciplinary environments.
Rob Hickling, Director, Information Technology & Commercialization
Rob Hickling leads the Information Technology team at the Rick Hansen Institute with initiatives in several areas — software development, network infrastructure, secure web server operations, and secure data management. He has over 25 years IT industry experience in many different environments, with a primary focus in software development. Previously Rob was with Thomson Reuters (Corporate Treasury), Aeroinfo Systems (a division of Boeing Canada), PricewaterhouseCoopers eBusiness Consulting, Rewardstream (Customer Loyalty Services), Microsoft, Canadian Airlines International, and self-employed with clients such as Unocal Oil Southeast Asia, Geographics, and the Canadian Reference Laboratory.
Marianne Lowe, CPHR, Director, Human Resources
Marianne Lowe leads the HR function for RHI and served as the Director of Human Resources for both the Institute and the Rick Hansen Foundation from 2013-2016. She is responsible for designing and implementing all aspects of the Institute's human resources and operational policies and procedures. Marianne holds the Chartered Professional in Human Resources (CPHRTM) designation and has a BA from the University of Alberta and a Graduate Diploma in Human Resource Development from Curtin University of Technology in Perth, Australia. She has over 20 years of experience in a variety of environments working in human resources, communications, hospitality and tourism and event coordination. Prior to her current position, Marianne spent several years at the Rick Hansen Foundation and worked in staff training and development at the British Columbia Institute of Technology.
Daniel Hejcman, CPA, CA, Director, Finance
Daniel Hejcman is an experienced Chief Financial Officer with more than fifteen years of finance and accounting experience, including five years of KPMG public audit experience. He worked for many large public and private organizations like WSP Global, Peter Kiewit Infrastructure, RBC Financial and Continental.
Mr. Hejcman is the financial executive that serves as the Director of Finance for the Rick Hansen Institute, where he manages their financial operations, accounting, reporting, leadership and supports the board of directors in financial oversight. He is known for his financial reporting expertise, strategic planning, team leadership and technical accounting skills. Mr. Hejcman is also the CFO and President of PEAK CPA Ltd., a CPA Public Practice specialized in CFO Executive Advisory.
Tom Philpott, MBA, MHA, PMP, CHE, Director, Project Management Office
Tom has over thirteen years of health administration experience, beginning as a senior advisory in the executive office of the McGill University Health Centre (MUHC) in 2005 after completing his MHA at the University of Ottawa and MBA at the Richard Ivey School of Business (Western University). His journey has included being programme manager on the Public-Private Partnership portion of the $1.3 B MUHC redevelopment project, project manager on an Enterprise Resource Planning system implementation, Executive Director of the Community for Excellence in Health Governance, Strategic Priority Consultant at Capital District Health Authority (Halifax) and Executive Director at Kids Brain Health Network (a federal Network of Centres of Excellence). This wide-ranging experience allows him to contribute to RHI's mission in a number of ways, most notably in terms of implementing organizational project management methodologies, including governance operational process changes, to help ensure that the work of RHI is providing benefit to Canadians and those living with SCI. Tom is also providing additional support in provincial relations, most notably in Quebec and New Brunswick. He is fluent in French and Spanish.
Daniel Rogers, BSc, PMP, Associate Director, Clinical Research Operations
Daniel Rogers is responsible for managing RHI's clinical research projects and supporting RHI's Clinical Research Network – a collaboration of SCI researchers and clinicians based at acute and rehabilitation centres across Canada and Internationally who participate in the Rick Hansen Spinal Cord Injury Registry and other RHI-sponsored projects. The clinical research operations teams provide a wide range of project management and research support services to the projects within the various RHI programs.
Daniel, a Project Management Professional (PMP), has been managing research activities for the past 15 years in pre-clinical and clinical research environments across academic, public health and not-for-profit sectors. Prior to joining RHI in 2011, Daniel spent 10 years at the University of British Columbia within the Centre Molecular Medicine & Therapeutics and then with the Division of Nephrology.